Maryam Kazerani

9PUBLICATIONS
33CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)Tumour immunologyHaematological tumoursGenome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 01, 2026
TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome.

|Feb 24, 2026
FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion.

Lisa Rohrbacher, Daniel Nixdorf, Helena Stadler

|Dec 04, 2025
TNF-α and IFN-γ differentially regulate AML cell susceptibility to CD70-antibody-mediated cytotoxicity.

Monika Sponheimer, Kieron White, Michelle Ulrich

|Dec 01, 2025
FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion.

Lisa Rohrbacher, Daniel Nixdorf, Helena Stadler

|Dec 17, 2024
Histone methyltransferase SETDB1 safeguards mouse fetal hematopoiesis by suppressing activation of cryptic enhancers.

Maryam Kazerani, Filippo Cernilogar, Alessandra Pasquarella

|Aug 22, 2024
Evolution of T-cell fitness through AML progression: enhanced bispecific T-cell engager-mediated function of bone marrow T cells at remission compared to initial diagnosis and relapse.

Maryam Kazerani, Anetta Marcinek, Nora Philipp

Pageof 2

Frequent Collaborators

6 joint publications

Daniel Nixdorf

6 joint publications

Veit L Buecklein

5 joint publications

Nora Philipp

5 joint publications

Marion Subklewe